Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

"What if I told you," Joel Weinstock said, "there were countries where the doctors had never seen hay fever?" It is another piece of evidence, another "aha" moment in the global medical mystery that Weinstock - the chief of gastroenterology and hepatology at Tufts-New England Medical Center - has narrowed down to one chief suspect: the worms. Weinstock, 59, specializes in studying why immunological diseases ... are on the rise in developed countries but remain relatively uncommon in undeveloped countries. He believes these diseases, many of which were almost unheard of 100 years ago, are because of changes in our environment, a lack of exposure to something. And he thinks that something may be the worms. "We realized that one thing people always had was intestinal worms," he said. The parasites that we have been told to avoid - such as hookworm and pinworm - may be the good guys, while excessive hygiene may be the bad guy. "I get about 5,000 e-mails a year from patients all over the world asking what to do," he said. "People know that something isn't right. They keep their kids in the cleanest environments and they get asthma. We get all of these things that were rare becoming common. And a lot of it comes down to hygiene. Excessive hygiene can potentially lead to disease." The "hygiene hypothesis," which was first proposed nearly two decades ago, argues that aspects of cleanliness prevent the immune system from programming itself to fight off disease. "The big question is what are those aspects? We don't want to go back to the standards of the 1800s," Weinstock said. "Public hygiene and cleanliness are very good for us, but removing ourselves entirely from our natural environment is bad for us. We need to figure out the aspects of dirt and exposure that are good for us and hopefully we can find a balance."

Note: For many reliable reports on health issues, click here.

Pharmaceutical ingredients exported from China are often made by chemical companies that are neither certified nor inspected by Chinese drug regulators, The New York Times has found. Because the chemical companies are not required to meet even minimal drug-manufacturing standards, there is little to stop them from exporting unapproved, adulterated or counterfeit ingredients. The substandard formulations made from those ingredients often end up in pharmacies in developing countries and for sale on the Internet, where more Americans are turning for cheap medicine. [At a pharmaceutical trade show in Milan], the Times identified at least 82 Chinese chemical companies that said they made and exported pharmaceutical ingredients — yet not one was certified by the State Food and Drug Administration in China, records show. Nonetheless, the companies were negotiating deals at the pharmaceutical show, where suppliers wooed customers with live music, wine and vibrating chairs. In China, chemical manufacturers that sell drug ingredients fall into a regulatory hole. Pharmaceutical companies are regulated by the food and drug agency. Chemical companies that make products as varied as fertilizer and industrial solvents are overseen by other agencies. The problem arises when chemical companies cross over into drug ingredients. “We have never investigated a chemical company,” said Ms. Yan [Jiangying], deputy director of policy and regulation at the State Food and Drug Administration. “We don’t have jurisdiction.” China has an estimated 80,000 chemical companies, and the United States Food and Drug Administration does not know how many sell ingredients used in drugs consumed by Americans. The Times examined thousands of companies selling products on major business-to-business Internet trading sites and found more than 1,300 [Chinese] chemical companies offering pharmaceutical ingredients.

Note: For many other reliable reports concerning health, click here.

Every year, malnutrition kills five million children -- that's one child every six seconds. But now, the Nobel Prize-winning relief group "Doctors Without Borders" says it finally has something that can save millions of these children. It's cheap, easy to make and even easier to use. What is this miraculous cure? It's a ready-to-eat, vitamin-enriched concoction called "Plumpynut," an unusual name for a food that may just be the most important advance ever to cure and prevent malnutrition. "It's a revolution in nutritional affairs," says Dr. Milton Tectonidis, the chief nutritionist for Doctors Without Borders. "Now we have something. It is like an essential medicine. In three weeks, we can cure a kid that ... looked like they're half dead. It’s just, boom! It's a spectacular response," Dr. Tectonidis says. No kids need it more than ... in Niger, a desperately poor country in West Africa, where child malnutrition is so widespread that most mothers have watched at least one of their children die. Why are so many kids dying? Because they can't get the milk, vitamins and minerals their young bodies need. Mothers in these villages can't produce enough milk themselves and can't afford to buy it. Even if they could, they can't store it -- there’s no electricity, so no refrigeration. Powdered milk is useless because most villagers don't have clean water. Plumpynut was designed to overcome all these obstacles. Plumpynut is a remarkably simple concoction: it is basically made of peanut butter, powdered milk, powdered sugar, and enriched with vitamins and minerals. It tastes like a peanut butter paste. It is very sweet, and because of that kids cannot get enough of it. The formula was developed by a nutritionist. It doesn't need refrigeration, water, or cooking; mothers simply squeeze out the paste. Many children can even feed themselves. Each serving is the equivalent of a glass of milk and a multivitamin.

Bristol-Myers Squibb Co. and a former subsidiary have agreed to pay more than $515 million to settle federal and state investigations into their drug marketing and pricing practices. The civil settlement ... resolves a broad array of allegations against Bristol-Myers Squibb, dating from 1994 through 2005. Among them was a charge that the ... company illegally promoted the sale of Abilify, an anti-psychotic drug, for pediatric use and to treat dementia-related psychoses. Neither use is approved by the U.S. [FDA]. Although physicians are permitted to prescribe drugs for off-label uses, drug companies are prohibited from marketing them for uses that have not been approved by the FDA. U.S. Attorney Michael Sullivan said when pharmaceutical companies market drugs for unapproved uses, there is a potential risk that patients could be harmed, because the drugs have not been tested as rigorously as they are during the FDA approval process. The government also alleged the company paid illegal inducements in the form of consulting fees and trips to luxury resorts to influence doctors and other health care providers to buy and prescribe the company's drugs. The company's former generic drug subsidiary, Apothecon Inc., also was accused of giving illegal enticements to induce retail pharmacy and wholesale customers to buy its products. Bristol-Myers Squibb misreported its best price for the anti-depression drug Serzone, violating a law that requires drug companies to report their lowest price to Medicaid, prosecutors said. The company was selling Serzone to a larger commercial purchaser at a lower price, prosecutors said. Bristol-Myers Squibb and Apothecon also inflated prices for an assortment of oncology and generic drugs knowing that federal health care programs established reimbursement rates based on those prices, Sullivan said.

Note: For lots more on corporate corruption, click here.

The revelation that the diabetes drug Avandia can potentially cause heart disease is the latest in a string of pharmaceutical disappointments. Vioxx was pulled from the market in 2004 because it doubled the risks for heart attacks and strokes. Eli Lilly recently paid $750 million to settle lawsuits alleging that Zyprexa causes diabetes. Many have criticized the Food and Drug Administration as being too lax about monitoring drug safety. While those criticisms have merit, there is another culprit: the transformation of continuing medical education into an enterprise for drug marketing. The chore of teaching doctors how to practice medicine has been handed to the pharmaceutical industry. As a result, dangerous side effects are rarely on the curriculum. Most states require that doctors obtain a minimum number of credit hours of continuing medical education each year to maintain their medical licenses. Not so long ago, most of these courses were produced and paid for by universities and medical associations. But this has changed drastically over the past decade. Drug-industry financing of continuing medical education has nearly quadrupled since 1998, from $302 million to $1.12 billion. Half of all continuing medical education courses in the United States are now paid for by drug companies, up from a third a decade ago. Because pharmaceutical companies now set much of the agenda for what doctors learn about drugs, crucial information about potential drug dangers is played down, to the detriment of patient care. For example, GlaxoSmithKline footed the bill for dozens of educational courses intended to emphasize the benefits of Avandia over other drugs.

Note: For a concise, reliable overview of medical corruption, click here.

By Dr. Michael Wilkes. When is a disease really a disease? Young doctors in training work hard, and so do lots of other people. When people work 24 hours in a row ... the body feels tired. Is this fatigue an abnormal physiologic state requiring medication and treatment, or is it a normal part of belonging to the human race? If abnormal, then doctors and pharmaceutical companies argue that the fatigue requires treatment. If it is normal -- despite a movement to label it as an illness -- then post-work fatigue belongs to the growing phenomenon of disease-mongering. "Disease-mongering" ... is the process of trying to convince healthy people that they are sick, or people with minor problems that they have extremely worrisome symptoms. This is all in an attempt to sell treatments. Countless examples of disease-mongering are driven by the pharmaceutical industry's drive to sell drugs. Conditions such as female sexual dysfunction syndrome, premenstrual dysphoric disorder, toenail fungus, baldness and social anxiety disorder (a.k.a. shyness) are a few places where the medical community has stepped in, thereby turning normal or mild conditions into diseases for which medication is the treatment. Most pharmaceutical companies devote huge amounts of money to prevent, control and cure diseases. When their profits don't match corporate expectations, they invent "new" diseases to be cured by existing drugs. What happens to real diseases when [the media] are filled with information promoting disease mongering? Government funding for public health campaigns pales by comparison with the billions spent by pharmaceutical companies on disease mongering intended to increase the markets for their products.

Note: For more reliable information about major corruption in the pharmaceutical industry, click here.

An alarming number of U.S. troops are having severe reactions to some of the vaccines they receive in preparation for going overseas. "This is the worst cover-up in the history of the military," said an unidentified military health officer who fears for his job. A shot from a syringe is leaving some U.S. servicemen and women on the brink of death. Lance Corporal David Fey, 20, has dialysis three days a week. His kidneys are failing, his military career is over, and he feels like his country abandoned him. Fey said he loved every minute of boot camp and combat training at 29 Palms in California. But on Nov. 28, 2005, his life would change forever. Fey was one of a group of Marines who lined up for an undisclosed shot. "They asked us our name. We stood on these yellow footprints, and they gave us this shot, and we got the rest of the day off," he recalled. "After that shot, I started swelling up. I gained 30 pounds of water. My eyes swelled up where I couldn't see. I started snoring. I developed a rash on my hand." Three weeks later, Fey was back in Clermont County on his death bed at Clinton Memorial Hospital. His kidneys were failing, and his body was so swollen that it left stretch marks. Fey is one of a growing number of U.S. servicemen and women who are getting sick after receiving vaccines. And the ... Department of Defense medical officer who spoke with [WLWT] said that the number is up in the thousands. The symptoms range from joint aches and pains and arthritic symptoms to death. The officer said those who have claimed to have had adverse reactions to shots are treated like it is all in their heads. Asked whether servicemen and women are receiving experimental vaccines, the officer said, "I would hope to God not. But from what I've seen, I would have to say yes."

The ties between doctors and drug manufacturers are close indeed. Most physicians (94 percent) reported some type of relationship with the pharmaceutical industry ... according to [a] study, published in the April 26 issue of the New England Journal of Medicine. Most of these relationships involved receiving food in the workplace (83 percent) or receiving drug samples (78 percent). More than one-third of the respondents (35 percent) were reimbursed for costs associated with professional meetings or continuing medical education, while more than one-quarter (28 percent) were paid for consulting, delivering lectures or enrolling patients in clinical trials. Over the past two decades, physician-industry relationships have attracted increasing scrutiny. One review found that, on average, physicians meet with industry representatives four times a month, and medical residents accept six gifts annually from industry representatives. "We know that these relationships have benefits and risks, and we know that they benefit the companies that are involved, and we know from our data that they benefit doctors," said study author Eric G. Campbell, an assistant professor of health care policy at the Institute for Health Policy at Harvard Medical School. "The real question is to what extent do these relationships benefit patients, and the answer is, we don't know." Campbell said that he found it hard to believe that free football tickets for a doctor would trickle down to benefit patients.

Note: For an excellent article by one of the foremost doctors in the nation on how the pharmaceutical industry has corrupted politics and damaged our health, click here.

The most widely prescribed sleeping pills can cause strange behavior like driving and eating while asleep, the Food and Drug Administration said yesterday, announcing that strong new warnings will be placed on the labels of 13 drugs. Use of those medications and other similar drugs has soared by more than 60 percent since 2000, fueled by television, print and other advertising. Last year, makers of sleeping pills spent more than $600 million on advertising aimed at consumers. Sales in the United States of Ambien and Lunesta alone last year exceeded $3 billion. Last year ... some users of the most widely prescribed drug, Ambien, started complaining online and to their doctors about unusual reactions ranging from fairly benign sleepwalking episodes to hallucinations, violent outbursts, nocturnal binge eating and — most troubling of all — driving while asleep. Sleep-drivers reported frightening episodes in which they recalled going to bed, but woke up to find they had been arrested roadside in their underwear or nightclothes. The agency also received reports of people making phone calls, purchasing items over the Internet, or having sex under the influence of sleep medication. In each case the consumers had no recollection of the events, which they said had occurred after they took their pills and headed for bed. "Hopefully this will make doctors think twice before blindly giving patients a prescription," said Dr. Mahowald. He also criticized marketing of the products. "I personally think the extent of advertising has just been unconscionable," he said.

Note: A reliable insider told us of a harrowing story where his company and the FDA made a secret agreement not to report numerous deaths resulting from one test drug so that it would pass and bring major profits. For lots more reliable, verifiable information on major corruption in the drug companies affecting your health, click here.

The Agriculture Department has given a preliminary green light for the first commercial production of a food crop engineered to contain human genes, reigniting fears that biomedically potent substances in high-tech plants could escape and turn up in other foods. The plan ... calls for large-scale cultivation in Kansas of rice that produces human immune system proteins in its seeds. The proteins are to be extracted for use as an anti-diarrhea medicine and might be added to health foods such as yogurt and granola bars. Critics are assailing the effort, saying gene-altered plants inevitably migrate out of their home plots. In this case, they said, that could result in pharmacologically active proteins showing up in the food of unsuspecting consumers. Although the proteins are not inherently dangerous, there would be little control over the doses people might get exposed to, and some might be allergic to the proteins, said Jane Rissler of the Union of Concerned Scientists. "This is not a product that everyone would want to consume," Rissler said, adding that other companies grow such plants indoors or in vats. "It is unwise to produce drugs in plants outdoors."

Note: For a detailed analysis of the dangers of this genetically-modified rice program, click here.

Gov. Rick Perry on Thursday angrily defended his relationship with Merck & Co. and his executive order requiring that schoolgirls receive the drugmaker's vaccine against the sexually transmitted cervical-cancer virus. The Associated Press reported Wednesday that Perry's chief of staff had met with key aides about the vaccine on Oct. 16, the same day Merck's political action committee donated $5,000 to the governor's campaign. In issuing the order, the governor made Texas the first state to require the vaccine Gardasil for all schoolgirls. But many lawmakers have complained about his bypassing the Legislature altogether. The executive order has inflamed conservatives, who said it contradicts Texas' abstinence-only sexual education policies and intrudes into families' lives. Critics have previously questioned Perry's ties to Merck. Mike Toomey, Perry's former chief of staff, now lobbies for the drug company. And the governor accepted a total of $6,000 from Merck during his re-election campaign. Merck has waged a behind-the-scenes lobbying campaign to get state legislatures to require girls to get the three-dose vaccine to enroll in school. But on Tuesday the pharmaceutical company announced it was suspending the effort because of pressure from parents and medical groups. The Kentucky House on Thurday passed a bill that would require the vaccination for middle school girls unless their parents sign a form opposing it. Virginia lawmakers have also passed legislation requiring the vaccine, but the governor has not decided if he will sign it.

Note: The drug company lobby is the most powerful in the U.S., as reported by the former editor-in-chief of one of the most respected medical journals in the U.S. Click here for more.

Several government doctors say drug maker Eli Lilly & Co. subtly orchestrated medical guidelines for treatment of an often lethal blood infection, hoping to boost sales of a drug whose value is being debated. “This company is trying to insinuate its drug into many aspects of patient care that industry really shouldn’t be involved in,” said Dr. Naomi O’Grady, a critical care specialist at the National Institutes of Health. Three of her NIH colleagues claim in Thursday’s New England Journal of Medicine that Lilly worked through medical societies to influence standards for treating the blood infection, sepsis. Ultimately, Xigris was incorporated into the guidelines. Both the guidelines committee and a larger information campaign on sepsis were heavily funded by [Lilly]. Dr. Phil Dellinger, who helped lead the guidelines committee, said...“We’ve been catching grief because we’ve been taking a lot of Lilly money — and we’re appreciative of Lilly giving it.” The U.S. Food and Drug Administration approved Xigris in 2001, despite an evenly split vote by its advisory committee. The lead author of Thursday’s journal article, Dr. Peter Q. Eichacker, voted against approval. Some critics are unhappy that the drug, which works only for the sickest patients, was approved on the basis of a single experiment. Academic officials acknowledged in the published guidelines that Lilly gave more than 90 percent of $861,000 in grants for the campaign and medical recommendations. O’Grady, of NIH, said a panel of disease experts that she headed refused to endorse the sepsis guidelines largely because Lilly “convened the whole panel.”

Note: For lots more on how the powerful pharmaceutical industry endangers our lives, click here.

In 1972, the Tuskegee experiments on black people shocked the world. Now, a new report reveals that the official inquiry was a cover-up. The [syphilis] "trial," conducted between 1932 and 1972, involved 400 black sharecroppers. The Tuskegee "volunteers" were not to be treated, either with Salvarsan or even antibiotics after their discovery. Ignorant of the true goal of the trial, the participants were destined to be living, and dying, examples of the terrible course of the untreated illness. Tuskegee, after its exposure in the media in 1972, thus became a byword in America for racist medical experimentation. Soon after the Tuskegee revelations, fault was admitted, apologies made. Yet in time, historians of medicine, sociologists and social anthropologists began to play down the scandal. Tuskegee, they argued, was an understandable error, given the absence of viable antidotes in the 1930s. But renewed outrage over Tuskegee is about to explode with an investigation entitled Medical Apartheid, to be published in the US early next year. The public-health historian Harriet Washington will reveal ... that the Tuskegee trial was even more inhumane and morally degenerate than previously suspected. The role of Nurse Eunice Rivers became crucial. Above all, her task, aided by the study's doctors, was to ensure that the syphilitic men would receive no treatment, despite the extraordinary advances in treatment from the 1940s onwards. "By 1955," according to Washington, "nearly one-third of the autopsied men had died directly of syphilis and many of the survivors were suffering its deadliest complications."

Note: For lots more on the history humans used as guinea pigs in experiments by government: http://www.WantToKnow.info/humanguineapigs and http://www.WantToKnow.info/mindcontrollers10pg#human

The American Diabetes Association...privately enlisted an Eli Lilly & Co. executive to chart its growth strategy. The National Alliance on Mental Illness...lobbies for treatment programs that also benefit its drug-company donors. The National Gaucher Foundation...gets nearly all its revenue from one drugmaker, Genzyme Corp. Many patient groups and drug companies maintain close, multimillion-dollar relationships while disclosing limited or no details about the ties. An Inquirer examination of six groups, each a leading advocate for patients in a disease area, found that the groups rarely disclose such ties when commenting or lobbying about donors' drugs. Combined, the six received at least $29 million from drug companies last year. The amount ranged from 2 percent to 7 percent of revenue at the Arthritis Foundation, to 89 percent to 91 percent at the much smaller National Gaucher Foundation. The funding usually comes from the companies' marketing or sales divisions, not charity offices. Grants often rise with promotional spending as a drug hits the market and fall when sales ebb. Donations from Merck and Pfizer Inc. to the Arthritis Foundation more than doubled, to at least $1.65 million combined, in 2000 as they launched Vioxx and Celebrex. Merck explicitly wove the foundation into sales strategies. In 2000-2001, the American Diabetes Association did not disclose an unusual gift from Lilly: a lent executive, Emerson "Randy" Hall Jr., who moved into its Alexandria, Va., headquarters and coached it on growth strategies, all paid by Lilly.

Note: If you want to understand how the huge pharmaceutical industry influences what you know about their drugs, this article is a must read. You may first want to read a riveting two-page summary of an exposé by the former editor-in-chief of the New England Journal of Medicine, who details major collusion and corruption in the pharmaceutical industry at http://www.WantToKnow.info/healthcoverup

Beginning in 1997, Pharmacia, currently a subsidiary of Pfizer, sought to boost its sales of the drug Genotropin. To that end, the company illegally marketed the drug to spur growth in short children and as an anti-aging drug for adults looking for the fountain of youth. In a nutshell, the off-label marketing scheme included direct payments to doctors, all-expense paid junkets for doctors, financial incentives to distributors and phony consultant contracts to funnel payments for the off-label promotion. As a result of the scheme's success, sales of the Genotropin sky-rocketed and over the years, Medicaid and other public healthcare programs paid millions of dollars for its improper use. The full amount of damage to health care programs is not yet known. "But this much is certain," former Pfizer Vice President turned whistleblower, Dr Peter Rost, says, "Pharmacia turned Genotropin into a cash cow by illegally peddling a dangerous drug to make short kids tall and their grandparents young." Genotropin is a man made human growth hormone approved to treat a limited range of hormonal deficiencies. The FDA has never approved the drug to spur growth for children without hormonal deficiencies or to prevent aging. Dr Rost joined Pharmacia in June of 2001 as a VP of Marketing. On May 22, 2003, Dr Rost became aware of the pervasive nature of ongoing illegal activity. [He then] decided to file a lawsuit ... alleging fraud relating to the off-label marketing of Genotropin and delivered a copy of the complaint to the US Attorney's Office on June 4, 2003.

Note: Read an excellent article on Dr. Rost and other major whistleblowers from the pharmaceutical industry.

According to reports published today...healthy people are being turned into patients by drug firms which publicise mental and sexual problems and promote little-known conditions only then to reveal the medicines they say will treat them.The studies, published in a respected medical journal, accuse the pharmaceutical industry of "disease mongering" - a practice in which the market for a drug is inflated by convincing people they are sick and in need of medical treatment. The "corporate-sponsored creation of disease" wastes resources and may even harm people because of the medication they turn to, the researchers add. In 11 papers in the journal Public Library of Science Medicine, experts from Britain, the US and elsewhere argue that new diseases are being defined by specialists who are often funded by the drug industry.According to the researchers, the campaigns boost drug sales by medicalising aspects of normal life.

Note: For more on how the pharmaceutical companies can negatively impact your health and your wallet:
http://www.WantToKnow.info/healthcoverup

From 1994 to 2003, medical research funded by pharmaceutical and biotechnology companies steadily increased and now surpasses research funded by government or public sources, according to a review of the most frequently cited studies. In the new study, reported in the March 17th online issue of the British Medical Journal, the sponsorship of 289 articles...was determined. Overall, 60% of articles had government or public funding and 36% were funded by industry. However, this masks the dramatic rise in industry funding that occurred over time: in 1994, roughly 30% of articles were funded by industry compared with over 50% in 2001. Moreover, 65 of the 77 most cited randomized controlled trials involved industry funding. "Medical research should reflect public needs more closely and the efforts of all of those involved should be better coordinated," the authors emphasize.

Women who eat GM [genetically modified] foods while pregnant risk endangering their unborn babies, startling new research suggests. The study...found that more than half of the offspring of rats fed on modified soya died in the first three weeks of life, six times as many as those born to mothers with normal diets. Six times as many were also severely underweight. The research - which is being prepared for publication - is just one of a clutch of recent studies that are reviving fears that GM food damages human health. Italian research has found that modified soya affected the liver and pancreas of mice. Australia had to abandon a decade-long attempt to develop modified peas when an official study found they caused lung damage. The World Trade Organisation is expected next month to support a bid by the Bush administration to force European countries to accept GM foods. The Monsanto soya is widely eaten by Americans.

Note: Though the European press provides good coverage, the US media is amazingly quiet on the issue of GMOs, which is so vital to our health. For an excellent overview: http://www.wanttoknow.info/deception10pg

DuPont Co. has agreed to pay $10.25 million in fines and $6.25 million for environmental projects in a settlement with the Environmental Protection Agency over the company's alleged failure to report the dangers of a toxic chemical used to make Teflon. EPA officials said the settlement represents the largest civil administrative penalty the agency has ever obtained under any federal environmental statute. The EPA alleged that DuPont withheld information for more than 20 years about the health effects of PFOA. DuPont faced a potential fine of more than $300 million for not reporting that the chemical posed a substantial risk of injury to health or the environment. "The settlement allows us to put this matter behind us and move forward," said [DuPont general counsel Stacey] Mobley, who noted that the company has cut PFOA emissions from U.S. plant sites by 98 percent and hopes to reduce emissions even further by 2007. DuPont...still faces a federal criminal investigation of its actions concerning PFOA. In a draft report released in June, the majority of members on a scientific advisory board that reviewed the EPA's draft risk assessment concluded that the chemical is "likely" to be carcinogenic to humans.

[Gary] Butcher has been an extension veterinarian at the University of Florida's College of Veterinary Medicine since 1988. He was trained as a veterinarian specializing in avian diseases, and has a Ph.D. in poultry virology. Butcher begins his presentation with a slide that shows a "news flash" from the British press agency Reuters reporting that avian flu "poses the single biggest threat to the world right now." So far, however...no one has yet been proven to have given avian influenza to someone else. "The emphasis of all my work has changed to dealing with this madness," Butcher said Friday. "Realistically, avian influenza is not a threat to people, but everywhere you go, it has turned into a circus." Millions of chickens and waterfowl have been slaughtered in Asia...but Butcher said that of the billions of people who have probably been exposed, only about 120 have been reported to have fallen ill with avian flu. They were people who worked closely with chickens and came into contact with the birds' blood and feces. Not all health officials are sounding a warning about avian influenza, either. Dr. Marc Siegel, a practicing internist and associate professor of medicine at the New York University School of Medicine...isn't buying into the scare scenario. "If anything is contagious right now, it's judgment clouded by fear," Siegel said. [Butcher] said that although there is a potential that the virus could mutate, as it exists, it could not become an important disease in humans. "For it to become dangerous to humans, it has to go through a pretty significant genetic change. If you put this in perspective, it's not going to happen.

Note: When major corruption threatens to be exposed, those threatened know that by creating massive fear (such as a global pandemic), they can divert attention and keep money flowing into corrupt coffers. For more on this, click here and here.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.